SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Reata Pharmaceuticals, Inc. Contracts ApoCell, Inc. to Detect Innovative Biomarkers in a Phase II Clinical Study of RTA 402 for Diabetic Renal Disease